APO Research
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Piroxicam Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchPiroxicam Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam Capsules Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Piroxicam Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam Capsules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Piroxicam Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Piroxicam Capsules include Chongqing Kerui Pharmaceutical, Pfizer, Guangzhou Ouhua Pharmaceutica, Baiyunshan, Guangdong Zhongsheng Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Pidi Pharmaceutical, Teva Pharmaceuticals USA and SK Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Piroxicam Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Piroxicam Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Piroxicam Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piroxicam Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Piroxicam Capsules Segment by Company

Chongqing Kerui Pharmaceutical

Pfizer

Guangzhou Ouhua Pharmaceutica

Baiyunshan

Guangdong Zhongsheng Pharmaceutical

Guangdong Xinfeng Pharmaceutical

Guangdong Pidi Pharmaceutical

Teva Pharmaceuticals USA

SK Chemical

Nouvasant Group

Elikem Pharmaceuticals

DevLife

AdvaCare Pharma

Piroxicam Capsules Segment by Type

Regular Release

Modified Release

Piroxicam Capsules Segment by Application

Hospital

Clinic

Pharmacy

Piroxicam Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Piroxicam Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Piroxicam Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Piroxicam Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Piroxicam Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Piroxicam Capsules Industry Trends Table 2. Piroxicam Capsules Industry Drivers Table 3. Piroxicam Capsules Industry Opportunities and Challenges Table 4. Piroxicam Capsules Industry Restraints Table 5. Global Piroxicam Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Piroxicam Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Piroxicam Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Piroxicam Capsules Sales Market Share by Manufacturers Table 9. Global Piroxicam Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Piroxicam Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Piroxicam Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Piroxicam Capsules Manufacturers, Product Type & Application Table 13. Global Piroxicam Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Piroxicam Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Regular Release Table 17. Major Manufacturers of Modified Release Table 18. Global Piroxicam Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Piroxicam Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Piroxicam Capsules Sales Market Share by Type (2021-2026) Table 22. Global Piroxicam Capsules Sales Market Share by Type (2027-2032) Table 23. Global Piroxicam Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Piroxicam Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Piroxicam Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Piroxicam Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Piroxicam Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Pharmacy Table 31. Global Piroxicam Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Piroxicam Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Piroxicam Capsules Sales Market Share by Application (2021-2026) Table 35. Global Piroxicam Capsules Sales Market Share by Application (2027-2032) Table 36. Global Piroxicam Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Piroxicam Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Piroxicam Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Piroxicam Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Piroxicam Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Piroxicam Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Piroxicam Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Piroxicam Capsules Sales Market Share by Region (2021-2026) Table 44. Global Piroxicam Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Piroxicam Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Piroxicam Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Piroxicam Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Piroxicam Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Piroxicam Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Piroxicam Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Piroxicam Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Piroxicam Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Piroxicam Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Piroxicam Capsules Revenue Market Share by Region (2027-2032) Table 63. Chongqing Kerui Pharmaceutical Company Information Table 64. Chongqing Kerui Pharmaceutical Business Overview Table 65. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio Table 67. Chongqing Kerui Pharmaceutical Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pfizer Piroxicam Capsules Product Portfolio Table 72. Pfizer Recent Development Table 73. Guangzhou Ouhua Pharmaceutica Company Information Table 74. Guangzhou Ouhua Pharmaceutica Business Overview Table 75. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio Table 77. Guangzhou Ouhua Pharmaceutica Recent Development Table 78. Baiyunshan Company Information Table 79. Baiyunshan Business Overview Table 80. Baiyunshan Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Baiyunshan Piroxicam Capsules Product Portfolio Table 82. Baiyunshan Recent Development Table 83. Guangdong Zhongsheng Pharmaceutical Company Information Table 84. Guangdong Zhongsheng Pharmaceutical Business Overview Table 85. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio Table 87. Guangdong Zhongsheng Pharmaceutical Recent Development Table 88. Guangdong Xinfeng Pharmaceutical Company Information Table 89. Guangdong Xinfeng Pharmaceutical Business Overview Table 90. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio Table 92. Guangdong Xinfeng Pharmaceutical Recent Development Table 93. Guangdong Pidi Pharmaceutical Company Information Table 94. Guangdong Pidi Pharmaceutical Business Overview Table 95. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio Table 97. Guangdong Pidi Pharmaceutical Recent Development Table 98. Teva Pharmaceuticals USA Company Information Table 99. Teva Pharmaceuticals USA Business Overview Table 100. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio Table 102. Teva Pharmaceuticals USA Recent Development Table 103. SK Chemical Company Information Table 104. SK Chemical Business Overview Table 105. SK Chemical Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. SK Chemical Piroxicam Capsules Product Portfolio Table 107. SK Chemical Recent Development Table 108. Nouvasant Group Company Information Table 109. Nouvasant Group Business Overview Table 110. Nouvasant Group Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nouvasant Group Piroxicam Capsules Product Portfolio Table 112. Nouvasant Group Recent Development Table 113. Elikem Pharmaceuticals Company Information Table 114. Elikem Pharmaceuticals Business Overview Table 115. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio Table 117. Elikem Pharmaceuticals Recent Development Table 118. DevLife Company Information Table 119. DevLife Business Overview Table 120. DevLife Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. DevLife Piroxicam Capsules Product Portfolio Table 122. DevLife Recent Development Table 123. AdvaCare Pharma Company Information Table 124. AdvaCare Pharma Business Overview Table 125. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AdvaCare Pharma Piroxicam Capsules Product Portfolio Table 127. AdvaCare Pharma Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Piroxicam Capsules Distributors List Table 131. Piroxicam Capsules Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Piroxicam Capsules Product Image Figure 2. Global Piroxicam Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Piroxicam Capsules Sales (2021-2032) & (K Units) Figure 5. Global Piroxicam Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Piroxicam Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Regular Release Image Figure 9. Modified Release Image Figure 10. Global Piroxicam Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Piroxicam Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Piroxicam Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Piroxicam Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Piroxicam Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Piroxicam Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Pharmacy Image Figure 19. Global Piroxicam Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Piroxicam Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Piroxicam Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Piroxicam Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Piroxicam Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Piroxicam Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Piroxicam Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Piroxicam Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Piroxicam Capsules Sales Market Share by Country (2021-2032) Figure 39. China Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Piroxicam Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Piroxicam Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Piroxicam Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Piroxicam Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Piroxicam Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Piroxicam Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Piroxicam Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Piroxicam Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Piroxicam Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Piroxicam Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Release
  • Modified Release
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Pfizer
  • Guangzhou Ouhua Pharmaceutica
  • Baiyunshan
  • Guangdong Zhongsheng Pharmaceutical
  • Guangdong Xinfeng Pharmaceutical
  • Guangdong Pidi Pharmaceutical
  • Teva Pharmaceuticals USA
  • SK Chemical
  • Nouvasant Group
  • Elikem Pharmaceuticals
  • DevLife
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Piroxicam Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Piroxicam Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Piroxicam Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Piroxicam Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Piroxicam Capsules Market Dynamics
  1. 2.1 Piroxicam Capsules Industry Trends
  2. 2.2 Piroxicam Capsules Industry Drivers
  3. 2.3 Piroxicam Capsules Industry Opportunities and Challenges
  4. 2.4 Piroxicam Capsules Industry Restraints
3 Piroxicam Capsules Market by Manufacturers
  1. 3.1 Global Piroxicam Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Piroxicam Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Piroxicam Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Piroxicam Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Piroxicam Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Piroxicam Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Piroxicam Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Piroxicam Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Piroxicam Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Piroxicam Capsules Tier 1, Tier 2, and Tier 3
4 Piroxicam Capsules Market by Type
  1. 4.1 Piroxicam Capsules Type Introduction
  2. 4.1.1 Regular Release
  3. 4.1.2 Modified Release
  4. 4.2 Global Piroxicam Capsules Sales by Type
  5. 4.2.1 Global Piroxicam Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Piroxicam Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Piroxicam Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Piroxicam Capsules Revenue by Type
  9. 4.3.1 Global Piroxicam Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Piroxicam Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Piroxicam Capsules Revenue Market Share by Type (2021-2032)
5 Piroxicam Capsules Market by Application
  1. 5.1 Piroxicam Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Piroxicam Capsules Sales by Application
  6. 5.2.1 Global Piroxicam Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Piroxicam Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Piroxicam Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Piroxicam Capsules Revenue by Application
  10. 5.3.1 Global Piroxicam Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Piroxicam Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Piroxicam Capsules Revenue Market Share by Application (2021-2032)
6 Global Piroxicam Capsules Sales by Region
  1. 6.1 Global Piroxicam Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Piroxicam Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Piroxicam Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Piroxicam Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Piroxicam Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Piroxicam Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Piroxicam Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Piroxicam Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Piroxicam Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Piroxicam Capsules Revenue by Region
  1. 7.1 Global Piroxicam Capsules Revenue by Region
  2. 7.1.1 Global Piroxicam Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Piroxicam Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Piroxicam Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Piroxicam Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Piroxicam Capsules Revenue (2021-2032)
  8. 7.2.2 North America Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Piroxicam Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Piroxicam Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Piroxicam Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Piroxicam Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical
  2. 8.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Piroxicam Capsules Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Guangzhou Ouhua Pharmaceutica
  14. 8.3.1 Guangzhou Ouhua Pharmaceutica Company Information
  15. 8.3.2 Guangzhou Ouhua Pharmaceutica Business Overview
  16. 8.3.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
  18. 8.3.5 Guangzhou Ouhua Pharmaceutica Recent Developments
  19. 8.4 Baiyunshan
  20. 8.4.1 Baiyunshan Company Information
  21. 8.4.2 Baiyunshan Business Overview
  22. 8.4.3 Baiyunshan Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baiyunshan Piroxicam Capsules Product Portfolio
  24. 8.4.5 Baiyunshan Recent Developments
  25. 8.5 Guangdong Zhongsheng Pharmaceutical
  26. 8.5.1 Guangdong Zhongsheng Pharmaceutical Company Information
  27. 8.5.2 Guangdong Zhongsheng Pharmaceutical Business Overview
  28. 8.5.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
  30. 8.5.5 Guangdong Zhongsheng Pharmaceutical Recent Developments
  31. 8.6 Guangdong Xinfeng Pharmaceutical
  32. 8.6.1 Guangdong Xinfeng Pharmaceutical Company Information
  33. 8.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
  36. 8.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
  37. 8.7 Guangdong Pidi Pharmaceutical
  38. 8.7.1 Guangdong Pidi Pharmaceutical Company Information
  39. 8.7.2 Guangdong Pidi Pharmaceutical Business Overview
  40. 8.7.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
  42. 8.7.5 Guangdong Pidi Pharmaceutical Recent Developments
  43. 8.8 Teva Pharmaceuticals USA
  44. 8.8.1 Teva Pharmaceuticals USA Company Information
  45. 8.8.2 Teva Pharmaceuticals USA Business Overview
  46. 8.8.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals USA Recent Developments
  49. 8.9 SK Chemical
  50. 8.9.1 SK Chemical Company Information
  51. 8.9.2 SK Chemical Business Overview
  52. 8.9.3 SK Chemical Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SK Chemical Piroxicam Capsules Product Portfolio
  54. 8.9.5 SK Chemical Recent Developments
  55. 8.10 Nouvasant Group
  56. 8.10.1 Nouvasant Group Company Information
  57. 8.10.2 Nouvasant Group Business Overview
  58. 8.10.3 Nouvasant Group Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nouvasant Group Piroxicam Capsules Product Portfolio
  60. 8.10.5 Nouvasant Group Recent Developments
  61. 8.11 Elikem Pharmaceuticals
  62. 8.11.1 Elikem Pharmaceuticals Company Information
  63. 8.11.2 Elikem Pharmaceuticals Business Overview
  64. 8.11.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
  66. 8.11.5 Elikem Pharmaceuticals Recent Developments
  67. 8.12 DevLife
  68. 8.12.1 DevLife Company Information
  69. 8.12.2 DevLife Business Overview
  70. 8.12.3 DevLife Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DevLife Piroxicam Capsules Product Portfolio
  72. 8.12.5 DevLife Recent Developments
  73. 8.13 AdvaCare Pharma
  74. 8.13.1 AdvaCare Pharma Company Information
  75. 8.13.2 AdvaCare Pharma Business Overview
  76. 8.13.3 AdvaCare Pharma Piroxicam Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
  78. 8.13.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Piroxicam Capsules Value Chain Analysis
  2. 9.1.1 Piroxicam Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Piroxicam Capsules Production Mode & Process
  6. 9.2 Piroxicam Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Piroxicam Capsules Distributors
  9. 9.2.3 Piroxicam Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst